Press Releases and Statements

(WASHINGTON, D.C.) – Consumer Healthcare Products Association (CHPA) President & CEO Scott Melville released the below Statement today following President-elect Donald Trump’s recent nomination of Dr. Marty Makary to lead the U.S. Food and Drug Administration (FDA): 

(PHILADELPHIA) – The Consumer Healthcare Products Association (CHPA) today announced the election of two new board members following its November Board of Directors meeting in Philadelphia. The Association also announced the appointment of current CHPA board member, Greg Bradley, CEO of Foundation Consumer Healthcare, as Chair-Elect of the CHPA Board of Directors. Bradley will assume the two-year appointment as Board Chair in March 2025, when current CHPA Board Chair, Lisa Paley, President of Haleon’s North America Region, concludes her term.

(PHILADELPHIA) – The Consumer Healthcare Product’s Association’s (CHPA) Health In Hand Educational Foundation held its 9th Annual Gala last night at The Bellevue Hotel in Philadelphia. The widely attended fundraiser brought together 350 attendees from 98 companies across the self-care industry to celebrate and support the Foundation’s critical consumer-focused work to help people live happier, healthier lives through responsible self-care. In addition to highlighting Health In Hand’s key 2024 educational initiatives, the event program also included the announcement of the Foundation’s new board member, Mark Pearson, Reckitt’s Vice President of Marketing Health, and the winners of the 2024 U.S. Self-Care Marketing Awards.

“The president-elect has announced his intention to nominate Robert F. Kennedy, Jr. to serve as Secretary of Health and Human Services. 

(WASHINGTON, D.C.) – The Consumer Healthcare Products Association’s (CHPA) President and CEO Scott Melville released the following statement today in response to FDA’s Proposed Order regarding the status of over-the-counter (OTC) phenylephrine (PE):

CHPA released the below statement following the passage of A1848 by the New Jersey Assembly today. This legislation seeks to ban the sale of over-the-counter (OTC) weight loss diet pills and dietary supplements marketed for weight loss and muscle building to individuals under 18 years old. While CHPA accepts age restrictions on products explicitly marketed for weight loss, recent amendments to the bill have broadened its scope. The changes now unnecessarily encompass general health supplements containing certain ingredients – including creatine and green tea extract – which are commonly used in many products unrelated to weight loss.

CHPA was pleased to announce today that Dr. Doug Bierer has been honored with its prestigious William Cooley Regulatory & Scientific Affairs Career Achievement Award in recognition of his exceptional service and contributions to the consumer healthcare products industry.

(WASHINGTON, DC) – The Health In Hand Foundation today released the following statement announcing the 2024 U.S. Self-Care Marketing Awards finalists. Winners for each category will be announced at the 9th annual Health In Hand Foundation Gala on November 13 at The Bellevue Hotel in Philadelphia. Specific awards will recognize the strategic innovation and marketing expertise of CHPA member companies across over-the-counter (OTC) medicine, consumer medical device, and dietary supplement categories.

The Consumer Healthcare Products Association (CHPA) released the following statement in response to a recent study published in Environment International regarding the presence of metals in certain tampon products. The study did not assess the risk of metal exposure to tampon users.

The Consumer Healthcare Products Association (CHPA) released the following statement today in response to Aylstock, Witkin, Kreis & Overholtz, PLLC filing a Citizen Petition with the U.S. Food and Drug Administration (FDA), requesting the Agency “recall and suspend sales of benzoyl peroxide (BPO) from the US Market due to the presence of benzene.”